Encompass Health Co. (NYSE:EHC) Shares Acquired by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. grew its holdings in Encompass Health Co. (NYSE:EHC) by 14.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,017 shares of the company’s stock after buying an additional 5,647 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Encompass Health were worth $4,254,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of EHC. O Shaughnessy Asset Management LLC raised its holdings in Encompass Health by 3.9% during the first quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company’s stock worth $351,000 after purchasing an additional 160 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its holdings in Encompass Health by 1.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 61,057 shares of the company’s stock worth $5,037,000 after purchasing an additional 578 shares during the last quarter. Natixis raised its holdings in Encompass Health by 163.1% during the first quarter. Natixis now owns 855 shares of the company’s stock worth $71,000 after purchasing an additional 530 shares during the last quarter. Lazard Asset Management LLC raised its holdings in Encompass Health by 18.1% during the first quarter. Lazard Asset Management LLC now owns 10,914 shares of the company’s stock worth $900,000 after purchasing an additional 1,676 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in Encompass Health by 614.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 540,519 shares of the company’s stock worth $44,637,000 after purchasing an additional 464,897 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on EHC. Stephens reaffirmed an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Truist Financial reissued a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays raised their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group raised their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Finally, Royal Bank of Canada raised their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $101.12 on Monday. The company has a market cap of $10.19 billion, a P/E ratio of 24.43, a P/E/G ratio of 1.32 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 52 week low of $63.78 and a 52 week high of $104.55. The business has a fifty day simple moving average of $97.11 and a 200-day simple moving average of $90.88.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the firm earned $0.86 earnings per share. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. Equities research analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.